Pliant Therapeutics, Inc. PLRX
Set alert
0.84 USD -0.02 -2.29%
At close · Nov 2
0.84 0.00 0.00%
After hours · Nov 2, 4:00 PM ET
0.8388 Day range 0.8554
0.8392 52-week range 1.80
- YTD
- -31.21%
- 1 year
- -50.05%
- Open
- 0.85
- Prev close
- 0.8589
- Mkt cap
- 51.96M
- Vol
- 385.68K
- Avg vol
- 400.40K
- EPS
- -1.50
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.8388
- High
- 0.8554
- Forward P/E
- -3.32
- Beta
- 1.09
- Short ratio
- 15.30
- Inst. own
- 111.96%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 7, 2024
- 50-d avg
- 14.08
- 200-d avg
- 13.14
- 1y target
- 40.18
Analyst view
Consensus: none
Price target (mean) 40.18 +4688.1% upside
Now 0.8392
- Target (low)
- 32.00
- Target (mean)
- 40.18
- Target (high)
- 47.00
Ratings (0m) 13 13 buy · 0 hold · 0 sell
- Strong buy5
- Buy8
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 13
- 1 month ago 13
- 2 months ago 13
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.97688 | -1.02 – -0.92 | -0.69 | -41.6% | 83.33K | 0.0% | 9 |
| Next quarter | -0.956 | -1.01 – -0.86 | -0.78 | -22.6% | 333.33K | 0.0% | 5 |
| Current year | -3.63 | -3.68 – -3.57 | -2.75 | -31.9% | 83.33K | -94.7% | 10 |
| Next year | -3.94 | -4.96 – -3.11 | -3.63 | -8.5% | 5.75M | +6800.3% | 11 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 8, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Sep 13, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 12, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Aug 8, 2024 | Cantor Fitzgerald | Reiterated | — | Overweight |
| Aug 8, 2024 | Oppenheimer | Maintained | Outperform | Outperform |
| Aug 8, 2024 | Needham | Reiterated | Buy | Buy |
| Jul 16, 2024 | Needham | Reiterated | Buy | Buy |
| Jul 16, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jun 7, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 15, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 7, 2024 | Citigroup | Maintained | Buy | Buy |
| May 7, 2024 | RBC Capital | Maintained | Outperform | Outperform |
| May 7, 2024 | Oppenheimer | Reiterated | Outperform | Outperform |
| May 7, 2024 | Needham | Reiterated | Buy | Buy |
| May 7, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Apr 10, 2024 | Needham | Reiterated | Buy | Buy |
| Mar 12, 2024 | Needham | Reiterated | Buy | Buy |
| Mar 5, 2024 | RBC Capital | Maintained | Outperform | Outperform |
| Feb 28, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Feb 28, 2024 | RBC Capital | Maintained | Outperform | Outperform |
| Feb 28, 2024 | Needham | Reiterated | Buy | Buy |
| Feb 5, 2024 | Needham | Maintained | Buy | Buy |
| Feb 5, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Nov 10, 2023 | RBC Capital | Maintained | Outperform | Outperform |
| Oct 4, 2023 | Needham | Reiterated | Buy | Buy |
| Sep 27, 2023 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Sep 27, 2023 | Needham | Reiterated | Buy | Buy |
| Sep 15, 2023 | Needham | Reiterated | Buy | Buy |
| Aug 29, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 22, 2023 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |